Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 4, 2011, Pages 1037-1044

  Rades, Dirk ^a   Kronemann, Stefanie ^a   Meyners, Thekla ^a   Bohlen, Guenther ^a   Tribius, Silke ^b   Kazic, Nadja ^c   Schroeder, Ursula ^a   Hakim, Samer G ^a   Schild, Steven E ^d   Dunst, Juergen ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^d MAYO CLINIC   (United States)

Author keywords

Cisplatin based radiochemotherapy; Head and neck cancer; Toxicity; Treatment outcomes

Indexed keywords

5-FLUOROURACIL; CIS-PLATIN; CISPLATIN 100; CONCURRENT CHEMOTHERAPY; HEAD-AND-NECK CANCER; HEMATOLOGIC TOXICITY; HEMOGLOBIN LEVELS; HISTOLOGIC GRADE; LOCOREGIONAL CONTROL RATE; MULTI VARIATE ANALYSIS; NEPHROTOXICITY; ORAL MUCOSITIS; PERFORMANCE STATUS; RADIOCHEMOTHERAPY; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKS; SURVIVAL RATE; TREATMENT OUTCOMES;

CHEMOTHERAPY; EDUCATION; MULTIVARIANT ANALYSIS; RADIOTHERAPY; TOXICITY;

PLATINUM COMPOUNDS;

CISPLATIN; FLUOROURACIL; HEMOGLOBIN;

ADULT; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; FEMALE; HEAD AND NECK CARCINOMA; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HISTOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NECK INJURY; NEPHROTOXICITY; OTOTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; RETROSPECTIVE STUDY; SEPSIS; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK; SURVIVAL RATE; TREATMENT DURATION; XEROSTOMIA;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; MIDDLE AGED; MOUTH NEOPLASMS; NAUSEA; NEOPLASM STAGING; PHARYNGEAL NEOPLASMS; RADIATION INJURIES; RADIODERMATITIS; STOMATITIS; TREATMENT OUTCOME; VOMITING;

EID: 79959371735     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.03.033     Document Type: Article

References (29)

1. V.A. Marcial, T.F. Pajak, and M. Mohiuddin Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck: Long-term results of the Radiation Therapy Oncology Group study 81-17 Cancer 66 1990 1861 1868 (Pubitemid 20385952)
2. M. Al-Sarraf, T.F. Pajak, and R.W. Byhardt Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24 Int J Radiat Oncol Biol Phys 37 1997 777 782 (Pubitemid 27181308)
3. G. Calais, M. Alfonsi, and E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081 2086 (Pubitemid 30019568)
4. V. Budach, A. Zurlo, J.C. Horiot European Organisation for Research and Treatment of Cancer (EORTC) Radiotherapy Group Achievements and future projects Eur J Cancer 38 Suppl. 4 2002 S134 S137
5. F. Denis, P. Garaud, and E. Bardet Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 2004 69 76 (Pubitemid 41095116)
6. V. Budach, M. Stuschke, and W. Budach Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 prospective randomized trial J Clin Oncol 23 2005 1125 1135 (Pubitemid 46202268)
7. B. Jeremic, and B. Milicic Pretreatment prognostic factors of local recurrence-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy Am J Clin Oncol 31 2008 213 218
8. B. Jeremic, and B. Milicic Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy Am J Clin Oncol 32 2009 163 168
9. B. Jeremic, and B. Milicic Pretreatment prognostic factors influencing distant metastasis-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy Am J Clin Oncol Epub 2009 Jun 5
10. B. Jeremic, B. Milicic, and A. Dagovic Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck J Clin Oncol 22 2004 3540 3548 (Pubitemid 41103660)
11. A. Trotti, R. Byhardt, and J. Stetz Common toxicity criteria, version 2.0: An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy Int J Radiat Oncol Biol Phys 47 2000 13 47 (Pubitemid 30179675)
12. D.W. Bruner, and T. Wasserman The impact on quality of life by radiation late effects Int J Radiat Oncol Biol Phys 31 1995 1353 1355
13. E.L. Kaplan, and P. Meier Non parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
14. D. Rades, F. Fehlauer, and M. Sheikh-Sarraf Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III-IV head and neck cancer Head Neck 30 2008 235 241 (Pubitemid 351251708)
15. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
16. M. Al-Sarraf, T.F. Pajak, and V.A. Marcial Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck: An RTOG study Cancer 59 1987 259 265 (Pubitemid 17232885)
17. V.A. Marcial, T.F. Pajak, and M. Mohiuddin Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck: Long-term results of the Radiation Therapy Oncology Group study 81-17 Cancer 66 1990 1861 1868 (Pubitemid 20385952)
18. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
19. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952 (Pubitemid 38580197)
20. L. Cerezo, I. Millan, and A. Torre Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer: A multivariate study of 492 cases Cancer 69 1992 1224 1234
21. C.R. Leemans, R. Tiwari, and J.J. Nauta Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma Cancer 71 1993 452 456 (Pubitemid 23021234)
22. S.A. Leibel, C.B. Scott, and M. Mohiuddin The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: Results of an analysis from the RTOG head and neck database Int J Radiat Oncol Biol Phys 21 1991 549 556
23. C. Robertson, A.G. Robertson, and J.H. Hendry Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers Int J Radiat Oncol Biol Phys 40 1998 319 329 (Pubitemid 28114375)
24. M.B. Barton, T.J. Keane, and T. Gadall The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer Radiother Oncol 23 1992 137 143
25. D.L. Kwong, J.S. Sham, and D.T. Chua The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 39 1997 703 710 (Pubitemid 27441440)
26. D. Rades, M. Stoehr, and N. Kazic Locally advanced stage IV squamous cell carcinoma of the head and neck: Impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy Int J Radiat Oncol Biol Phys 70 2008 1108 1114 (Pubitemid 351296118)
27. A. Becker, P. Stadler, and R.S. Lavay Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 46 2000 459 466 (Pubitemid 30067797)
28. 2 histography in patients with advanced head and neck cancer Strahlenther Onkol 177 2001 462 468 (Pubitemid 32861426)
29. 2 histography in patients with advanced head and neck cancer Radiother Oncol 57 2000 31 37